We’re in the midst of a “tripledemic” of COVID-19, flu and RSV. Hospitalizations are up 28% and test positivity is up 40%. For people who contract COVID, antiviral medication like Paxlovid can lower the risk of death by 48%, hospitalization by 30%, and long COVID by 26% – but only 11% have been able to access it recently. Intrivo Diagnostics C0-CEO Ron Gutman, will share his company’s breakthrough at-home COVID “Test to Treat” solutions.
